Can adults with type 1 diabetes get NHS diabetes technologies eligibility access?

Eligibility usually depends on clinical need, diabetes control, risk of hypoglycaemia, ability to use the technology safely, and agreement with your diabetes team. A specialist clinician assesses whether the technology is appropriate for your individual situation.

This eligibility applies to adults, meaning people aged 18 and over with type 1 diabetes, although local NHS policies may vary slightly in how they define transition from paediatric to adult services.

Insulin pump therapy may be considered for adults with type 1 diabetes who meet clinical criteria, such as difficulty achieving targets with multiple daily injections, frequent severe hypos, or specific lifestyle or medical needs.

Continuous glucose monitoring may be offered to adults with type 1 diabetes who need closer glucose tracking, especially if they have problematic hypoglycaemia, high glucose variability, or difficulty with finger-prick testing alone.

Flash glucose monitoring may be available to adults with type 1 diabetes who would benefit from easier glucose pattern monitoring, provided they can use the device correctly and it is judged clinically appropriate.

Common criteria include HbA1c levels, frequency of severe or nocturnal hypoglycaemia, hypoglycaemia unawareness, glucose variability, pregnancy plans, and whether standard insulin therapy is not meeting treatment goals.

Yes, a persistently high HbA1c can support eligibility if the diabetes team believes technology could improve glucose control, but eligibility is based on overall clinical assessment rather than HbA1c alone.

Yes, frequent or severe hypoglycaemia is a major factor in assessing eligibility because some technologies can help reduce lows and improve safety for adults with type 1 diabetes.

Yes, hypoglycaemia unawareness often strengthens the case for technology such as continuous glucose monitoring or pump therapy because it can help detect and prevent dangerous lows.

Yes, pregnancy planning can influence eligibility because tighter glucose management is important before and during pregnancy, and specialist teams may recommend suitable diabetes technology if clinically needed.

They may qualify if the difficulty with injections creates a significant barrier to safe and effective diabetes management, and the specialist team agrees that a device such as an insulin pump would help.

They may qualify if irregular work patterns, sleep cycles, or meal timing make glucose control difficult and a technology would improve safety and management.

A diabetes specialist team usually reviews your glucose records, treatment history, hypoglycaemia risk, daily routine, and ability to use the device before deciding whether the technology is suitable.

Usually yes. Eligibility is typically assessed by a diabetes specialist, such as a consultant or specialist nurse, rather than through a routine GP prescription alone.

It can. Other health conditions may increase the need for monitoring or make self-management harder, but they may also affect whether a particular device is practical or safe.

Switching between devices may be possible if your clinical needs change, but the diabetes team will review whether the new technology is still appropriate and cost-effective.

Yes, local NHS Integrated Care Board or hospital policies can affect access, so eligibility criteria and availability may differ slightly depending on where you live in the UK.

Yes, most technologies require regular use, ongoing follow-up, and the ability to respond to readings or alerts appropriately, so the team will assess whether you can use the device safely.

Access may be reviewed if the technology is not being used safely, is not meeting clinical goals, or circumstances change, but decisions are usually made with support from the diabetes team.

If access is refused, you can ask your diabetes team for the reasons, request a review, and discuss whether further evidence or an alternative device could support a new assessment.